Press release
Global Structural Heart Devices Market to grow at a CAGR of 10.08% to reach USD 25,264.95 million by 2032, Evaluates DelveInsight
DelveInsight's "Structural Heart Devices Market Insights, Competitive Landscape and Market Forecast-2032" report provides the current and forecast market outlook, forthcoming device innovation, challenges, market drivers and barriers. The report also covers the major emerging products and key Structural Heart Devices companies actively working in the market.
To know more about why North America is leading the market growth in the Structural Heart Devices market, get a snapshot of the report Structural Heart Devices Market Trends
https://www.delveinsight.com/sample-request/structural-heart-devices-market-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Structural Heart Devices Overview
Structural heart devices are medical devices designed to diagnose, repair, or replace damaged or defective structures within the heart, such as valves, walls, or chambers. These devices are commonly used to treat conditions like valvular heart disease, congenital heart defects, and cardiomyopathy without the need for open-heart surgery. Examples include transcatheter aortic valve replacement (TAVR) devices, left atrial appendage closure devices, occluders for septal defects, and annuloplasty rings. Structural heart devices support minimally invasive cardiac procedures, helping reduce recovery time, improve patient outcomes, and expand treatment options for high-risk or elderly patients who are not suitable for traditional surgery.
DelveInsight Analysis: The global structural heart devices market size is projected to grow significantly, rising from USD 11,752.22 million in 2024 and expanding at a CAGR of 10.08% to reach approximately USD 25,264.95 million by 2032, indicating strong and steady market expansion.
Structural Heart Devices Market Insights
Geographically, North America is expected to lead the global structural heart devices market, largely due to the increasing prevalence of structural heart disorders such as heart valve diseases, congenital heart defects, and other cardiac abnormalities.
To read more about the latest highlights related to Structural Heart Devices, get a snapshot of the key highlights entailed in the Structural Heart Devices Market Insights
https://www.delveinsight.com/report-store/structural-heart-devices-market-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Recent Developments in the Structural Heart Devices Market Report
• In April 2025, Edwards Lifesciences announced that its SAPIEN M3 mitral valve replacement system received CE Mark approval. The device is approved for treating patients with moderate-to-severe or severe mitral regurgitation (MR) who are not suitable for surgery or transcatheter edge-to-edge repair (TEER).
• In March 2025, Abbott announced new results from its TRILUMINATETM Pivotal trial, showing that the TriClipTM TEER system provides significant and lasting improvement in tricuspid regurgitation (TR) after two years.
• Thus, owing to such developments in the market, rapid growth will be observed in the Structural Heart Devices market during the forecast period
Key Players in the Structural Heart Devices Market
Some of the key market players operating in the Structural Heart Devices market include- Medtronic, Boston Scientific Corporation, Braile Biomedica, JOTEC GmbH, Edwards Life Sciences Corporation, Valcare Medical, W. L. Gore & Associates, Inc., Abbott Laboratories, Cardiovascular Systems, Inc., XELTIS BV, JenaValve Technology, Inc., Biomerics, Lepu Medical Technology (Beijing) Co., Ltd., LivaNova Inc., Comed B.V., TORAY, INDUSTRIES INC., Occlutech International AB, Microport Scientific Corporation, Meril Life Sciences Venus Medtech (Hangzhou) Inc., and others.
Which MedTech key players in the Structural Heart Devices market are set to emerge as the trendsetter explore @ Key Structural Heart Devices Companies
https://www.delveinsight.com/sample-request/structural-heart-devices-market-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Analysis on the Structural Heart Devices Market Landscape
The global structural heart devices market is largely being propelled by the increasing burden of cardiovascular and valvular diseases-such as aortic stenosis, mitral regurgitation, and congenital heart defects-which continues to drive the demand for advanced therapeutic options. At the same time, rapid technological progress in device innovation, including next-generation transcatheter valves, mitral repair technologies, and left atrial appendage closure systems, is improving performance, safety, and patient eligibility. The rising preference for minimally invasive cardiac procedures is also boosting market adoption, as catheter-based treatments offer lower surgical risks, reduced hospitalization time, and faster recovery compared to conventional open-heart surgery.
Together, these factors are positioning structural heart devices as a critical part of contemporary cardiovascular treatment, supporting strong market expansion throughout the 2025-2032 forecast period.
Scope of the Structural Heart Devices Market Report
• Coverage: Global
• Study Period: 2022-2032
• Structural Heart Devices Market Segmentation By Product Type: Repair Device [Occluders, Annuloplasty Devices, Valvuloplasty Devices, and Others] and Replacement device [Mechanical Heart Valves and Tissue Heart Valves]
• Structural Heart Devices Market Segmentation By Application: Atrial Septal Defect, Aortic Valve Stenosis, Patent Foramen Ovale, Ventricular Septal Defects, Mitral Regurgitation, and Others
• Structural Heart Devices Market Segmentation By End-User: Hospital, Ambulatory Surgical Centers, and Others
• Structural Heart Devices Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of the World
• Key Structural Heart Devices Companies: Medtronic, Boston Scientific Corporation, Braile Biomedica, JOTEC GmbH, Edwards Life Sciences Corporation, Valcare Medical, W. L. Gore & Associates, Inc., Abbott Laboratories, Cardiovascular Systems, Inc., XELTIS BV, JenaValve Technology, Inc., Biomerics, Lepu Medical Technology (Beijing) Co., Ltd., LivaNova Inc., Comed B.V., TORAY, INDUSTRIES INC., Occlutech International AB, Microport Scientific Corporation, Meril Life Sciences Venus Medtech (Hangzhou) Inc., and others
• Porter's Five Forces Analysis, Product Profiles, Case Studies, KOL's Views, Analyst's View
Interested in knowing how the Structural Heart Devices market will grow by 2032? Click to get a snapshot of the Structural Heart Devices Market Analysis
https://www.delveinsight.com/sample-request/structural-heart-devices-market-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Contact Us
Gaurav Bora
info@delveinsight.com
+14699457679
www.delveinsight.com
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing end-to-end comprehensive solutions to improve their performance.
Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Structural Heart Devices Market to grow at a CAGR of 10.08% to reach USD 25,264.95 million by 2032, Evaluates DelveInsight here
News-ID: 4251598 • Views: …
More Releases from DelveInsight Business Research
Global Neurofibromatosis Type 2 Pipeline Expands With 5+ Companies Advancing 5+ …
According to DelveInsight's analysis, the global Neurofibromatosis Type 2 (NF2) pipeline consists of more than five leading companies actively advancing over five therapeutic candidates. The assessment includes a comprehensive review of ongoing clinical trials, therapy mechanisms, routes of administration, and recent development activities.
DelveInsight's "Neurofibromatosis Type 2 Pipeline Insight, 2025" report delivers an extensive overview of the current clinical landscape and future growth potential across the Neurofibromatosis Type 2 market. The…
CDMO Market Poised for 7.25% CAGR Growth by 2032, According to DelveInsight
DelveInsight's report, "Contract Development Manufacturing Organization Market Insights, Competitive Landscape and Market Forecast-2032," offers detailed insights into current and future market trends, technological advancements, key challenges, growth drivers, and barriers. It also highlights major emerging offerings and profiles key CDMO companies shaping the market.
DelveInsight's analysis indicates that the Contract Development and Manufacturing Organization (CDMO) market is expanding rapidly, driven by the rising burden of chronic diseases such as cancer, cardiovascular…
Chronic Lower Back Pain Pipeline 2025: In-depth Clinical Trials Analysis and Eme …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Chronic Lower Back Pain pipeline constitutes 10+ key companies continuously working towards developing 10+ Chronic Lower Back Pain treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
"Chronic Lower Back Pain Pipeline Insight, 2025" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across…
Brain Metastasis from Breast Cancer Pipeline 2025: Therapies Under Investigation …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Brain Metastasis from Breast Cancer pipeline constitutes 10+ key companies continuously working towards developing 10+ Brain Metastasis from Breast Cancer treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
"Brain Metastasis from Breast Cancer Pipeline Insight, 2025" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and…
More Releases for Device
Medical Device Regulatory Affairs Market Medical Device Regulatory Affairs Marke …
"Medical Device Regulatory Affairs Market" in terms of revenue was estimated to be worth $ 6.7 billion in 2024 and is poised to reach $ 18.3 billion by 2034, growing at a CAGR of 10.8% from 2025 to 2034 according to a new report by InsightAce Analytic.
Request For Free Sample Pages:
https://www.insightaceanalytic.com/request-sample/1913
Latest Drivers Restraint and Opportunities Market Snapshot:
Key factors influencing the global medical device regulatory…
Surge In Wireless Device Usage Boosts Wireless Audio Device Market Driving Marke …
Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.
How Large Will the Wireless Audio Device Market Size By 2025?
In recent years, there has been remarkable growth in the wireless audio device market size. The market, which is projected to expand from $41.85 billion in 2024 to $52.37 billion in 2025, boasts a compound annual growth rate (CAGR) of 25.1%. Factors contributing…
Anti-snoring Device Market - Quiet Nights, Restful Sleep: Anti-snoring Device In …
Newark, New Castle, USA: The "Anti-snoring Device Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
Anti-snoring Device Market: https://www.growthplusreports.com/report/antisnoring-device-market/8931
This latest report researches the industry structure, sales, revenue,…
Global Watch Clock Measuring Device Market | Watch Clock Measuring Device Indust …
Watch, clock and measuring device market comprises of the sales of watch, clock, measuring device & related services to measure the time and physical quantity. Watch is portable timepiece, which is worn by people around the wrist, attached by a strap. Clock is a device used to measure and indicate time, using the pointers moving over a dial. Measuring device is an instrument used for measuring the various parameters in…
Peripheral Vascular Device Market Size, Peripheral Vascular Device Market Share, …
Global Peripheral Vascular Device Market Size is observed to gain traction owing to the factors such as increasing research and development for developing several new product, and rising funding by the private organizations.
Request for Sample of This Research Report @ https://bit.ly/2xjOKpC
Top Key Player:-
Abbott Laboratories
Braun Melsungen AG
Boston Scientific Corporation
R. Brad, Inc.
Cardinal Health, Inc.
Medtronic plc.
Cook Medical, Inc.
Teruma Corporation
Jude Medical, Inc.
The Spectranetics Corporation
Volcano Corporation
Peripheral vascular disorder (PVD) is a blood circulation disorder…
Medical Device Technologies Market - The Evolution of Medical Device Technologie …
The global medical device technologies market is anticipated to be boosted by various well-known players in the market. Some of these players that are dealing with the manufacturing of in vitro diagnostic devices hold a significant share in the global market. Whereas, the small market players are emerging from several developing nations, looking to set their foot in the market. Such measures are foreseen to change the market scenario in…
